138 related articles for article (PubMed ID: 6321878)
1. Relative incidence of primary liver cancer in cirrhosis in Austria. Etiological considerations.
Ferenci P; Dragosics B; Marosi L; Kiss F
Liver; 1984 Feb; 4(1):7-14. PubMed ID: 6321878
[TBL] [Abstract][Full Text] [Related]
2. [Prognosis of liver cirrhosis: results of a 14-year-long clinical follow-up study].
Marosi L; Ferenci P; Dragosics B; Kiss F; Pollak C; Minar E
Schweiz Med Wochenschr; 1983 Oct; 113(43):1586-92. PubMed ID: 6316488
[TBL] [Abstract][Full Text] [Related]
3. Relative risk of hepatocellular carcinoma in HBsAg positive vs alcoholic cirrhosis. A cross-sectional study.
Hadengue A; N'Dri N; Benhamou JP
Liver; 1990 Jun; 10(3):147-51. PubMed ID: 2166890
[TBL] [Abstract][Full Text] [Related]
4. [Primary hepatocarcinoma. Epidemiologic case-control study in the province of Bergamo].
Colloredo Mels G; Paris B; Bertone V; Angeli G
Minerva Med; 1986 Mar; 77(9-10):297-306. PubMed ID: 3005920
[TBL] [Abstract][Full Text] [Related]
5. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological studies of liver cirrhosis and hepatocellular carcinoma in a general hospital.
Bartók I; Remenár ; Tóth J; Duschanek P; Kanyár B
Hum Pathol; 1981 Sep; 12(9):794-803. PubMed ID: 6273290
[TBL] [Abstract][Full Text] [Related]
7. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
8. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.
Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R
J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis.
Fattovich G; Giustina G; Schalm SW; Hadziyannis S; Sanchez-Tapias J; Almasio P; Christensen E; Krogsgaard K; Degos F; Carneiro de Moura M
Hepatology; 1995 Jan; 21(1):77-82. PubMed ID: 7806171
[TBL] [Abstract][Full Text] [Related]
10. Unexpected high incidence of primary liver cancer in Geneva, Switzerland.
Tuyns AJ; Obradovic M
J Natl Cancer Inst; 1975 Jan; 54(1):61-4. PubMed ID: 163325
[TBL] [Abstract][Full Text] [Related]
11. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
Elzouki AN; Eriksson S
Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):989-94. PubMed ID: 8930564
[TBL] [Abstract][Full Text] [Related]
12. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.
Guyot E; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Beaugrand M; Charnaux N; Trinchet JC; Nahon P
J Hepatol; 2013 Feb; 58(2):312-8. PubMed ID: 23069476
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
14. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
15. Morphology of cirrhosis and occurrence of hepatocellular carcinoma in alcoholics with and without HBsAg and in non-alcoholic HBsAg-positive patients. A comparative autopsy study.
Nakanuma Y; Ohta G
Liver; 1983 Aug; 3(4):231-7. PubMed ID: 6323910
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in hong kong: a necropsy study: 1963-1976.
Gibson JB; Wu PC; Ho JC; Lauder IJ
Br J Cancer; 1980 Sep; 42(3):370-7. PubMed ID: 6252929
[TBL] [Abstract][Full Text] [Related]
17. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapy.
Hung CH; Wang JH; Lu SN; Hu TH; Lee CM; Chen CH
J Viral Hepat; 2017 Jul; 24(7):599-607. PubMed ID: 28130815
[TBL] [Abstract][Full Text] [Related]
19. Primary carcinoma of the liver. A histological study of 52 cases from Denmark.
Nørredam K
Acta Pathol Microbiol Scand A; 1979 Jul; 87A(4):227-36. PubMed ID: 224641
[TBL] [Abstract][Full Text] [Related]
20. [Primary liver carcinoma. Results of 268 autopsies].
Polterauer P; Ulrich W
Onkologie; 1982 Apr; 5(2):76-8. PubMed ID: 6285244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
